Characterization of distinct types of KRAS mutation and its impact on first-line platinum-based chemotherapy in Chinese patients with advanced non-small cell lung cancer

We performed this retrospective study to investigate whether the KRAS mutation status and its subtypes could predict the effect of first-line platinum-based chemotherapy in Chinese patients with non-small cell lung cancer (NSCLC). Patients received who had KRAS mutations were enrolled. Correlations...

Descripción completa

Detalles Bibliográficos
Autores principales: Jia, Yijun, Jiang, Tao, Li, Xuefei, Zhao, Chao, Zhang, Limin, Zhao, Sha, Liu, Xiaozhen, Qiao, Meng, Luo, Jiawei, Shi, Jinpeng, Yang, Hui, Wang, Yan, Xi, Lei, Zhang, Shijia, Gao, Guanghui, Su, Chunxia, Ren, Shengxiang, Zhou, Caicun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5686437/
https://www.ncbi.nlm.nih.gov/pubmed/29163686
http://dx.doi.org/10.3892/ol.2017.7016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5686437/
https://www.ncbi.nlm.nih.gov/pubmed/29163686
http://dx.doi.org/10.3892/ol.2017.7016

Ejemplares similares